InvestmentJul 9, 2026, 04:33 PM
Bone Biologics Raises $2.7M Net in Private Placement; Up to $6M More from Warrants
AI Summary
Bone Biologics Corp. announced a private offering to raise capital. The company priced a private offering with an investor to sell pre-funded warrants and Series F and G warrants to purchase 2,112,677 shares of common stock. The offering generated approximately $2.7 million in net proceeds, with the potential for an additional $6 million if all warrants are fully exercised. Proceeds will fund clinical trials, patent portfolio maintenance, and general corporate purposes.
Key Highlights
- Private offering of pre-funded warrants and Series F and G warrants.
- Sale of 2,112,677 pre-funded warrants and 2,112,677 Series F and G warrants.
- Combined purchase price of $1.419 per pre-funded warrant and accompanying warrants.
- Net proceeds from the offering approximately $2.7 million.
- Potential additional gross proceeds of approximately $6 million from warrant exercise.
- Series F and G warrants have an exercise price of $1.42 per share.
- Pre-funded warrants have an exercise price of $0.001 per share.
- Proceeds to fund clinical trials, patent portfolio, and working capital.
Price Impact
More from BBLG